WHO ICTRP trial
Treatment (AMDR) and Positive Psychotherapy in Depression and Quality of Life in…
IRCT20221228056957N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20221228056957N1 |
|---|---|
| Public title | Treatment (AMDR) and Positive Psychotherapy in Depression and Quality of Life in Men and Women with MS. |
| Scientific title | Comparison of the Effectiveness of (EMDR) and Positive Psychotherapy in Depression and Quality of Life in Men and Women with MS |
| Primary sponsor | Islamic Azad University |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Multiple sclerosis. Multiple sclerosis |
| Interventions | Intervention 1: The first group consists of 15 participants, which is a treatment method of desensitization with eye movements and reprocessing, which includes 8 sessions:1-taking history, 2-preparation, 3-evaluation, 4-desensitization… |
| Registration date | Feb 28, 2023 |
| Target size | 45 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: